BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Celgene Release: Oral Ozanimod Efficacy And Safety Results At 2 Years From Phase 2 Radiance Trial Of Patients With Relapsing Multiple Sclerosis Presented At 32nd ECTRIMS

  September 16, 2016

   · 

  6 min read
• Drug Development

  Merck & Co. Presents New Data Examining Durable Efficacy With Investigational Cladribine Tablets In Multiple Sclerosis

  September 16, 2016

   · 

  6 min read
• Business

  Concept Life Sciences Intensifies Its Push Into Medicinal Chemistry With New Senior Appointment At Peakdale Molecular Ltd.

  September 16, 2016

   · 

  1 min read
• Job Trends

  TGaS 2016 Incentive Compensation Landscape Shows Major Shifts In Payouts For Product Launch And Other Areas

  September 16, 2016

   · 

  2 min read
• Business

  Ligand Enters OmniAb License Agreement With TeneoBio

  September 16, 2016

   · 

  5 min read
• Drug Development

  AstraZeneca PLC Release: Phase III Combination Trial Of BYDUREON And FARXIGA Shows Significant Blood Sugar Reduction In Patients With Type 2 Diabetes

  September 16, 2016

   · 

  13 min read
• Biotech Beach

  Aerie Announces Public Offering Of Common Stock

  September 16, 2016

   · 

  5 min read
• Business

  Stentys Reports 2016 First-Half Results

  September 16, 2016

   · 

  1 min read
• Genetown

  Shire Announces Extension Of Investigator-Initiated Research (IIR) Grant

  September 16, 2016

   · 

  3 min read
• Genetown

  SAGE Therapeutics To Present At The Neurocritical Care Society 14th Annual Meeting

  September 16, 2016

   · 

  1 min read